Abstract
Transradial amputation is the most common level of major upper limb amputation. Despite the growing availability of multifunctional prosthetic hands, users’ control of these hands and overall functional abilities remain limited. The combination of pattern recognition control and targeted muscle reinnervation (TMR) surgery, an innovative technique where amputated nerves are transferred to reinnervate new muscle targets in the residual limb, has been used to improve prosthesis control of individuals with more proximal upper limb amputation levels (i.e., shoulder disarticulation and transhumeral amputation). The goal of this study was to determine if similar prosthesis control improvements could be seen for individuals with amputations at the transradial level. Participants controlled 3-5 grips with a multi-articulating hand prosthesis under myoelectric pattern recognition control for at least 8 weeks at home pre- and post-TMR surgery. Users gained some significant functional control benefits using a multi-articulating hand prosthesis with pattern recognition at 9-12 months post-TMR surgery. Additionally, a majority of subjects noted an improvement in their residual limb and phantom limb sensations post-TMR. An additional offline EMG analysis showed a decrease in grip classification error post-TMR surgery compared to pre-TMR surgery.
Competing Interest Statement
Coapt LLC was launched in 2012 and has a technology transfer and license agreement with the Shirley Ryan AbilityLab for the development of certain control technologies. Todd Kuiken and Levi Hargrove in the Center for Bionic Medicine at Shirley Ryan AbilityLab are responsible for the design, conduct and reporting of this research, and also have financial, management and ownership interests in Coapt LLC, which manufactures the device being tested in this research. These interests have been fully disclosed to Shirley Ryan AbilityLab and Northwestern University, and there is a conflict of interest management plan in place relative to this research study.
Clinical Trial
NCT02349035
Funding Statement
This work was supported by the National Institutes of Health NIH R01HD081525 and 5R01HD094861-04.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The Institutional Review Boards of both Northwestern University and Walter Reed National Military Medical Center's Institutional Review Board gave ethical approval for this work. All participants provided written informed consent.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
All data produced in the present study are available upon reasonable request to the authors
